Medicine Man Technologies IncGrey Market:SHWZView on Canadian Exchange
- LAST PRICE0.7000
- TODAY'S CHANGE (%)-0.0099 (-1.3946%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.6947 / 0.7099
- Day Range
- 52 Week Range
- Volume29,336
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SHWZ |
|---|---|---|
| 10:01 ET | 1769 | 0.6947 |
| 12:09 ET | 100 | 0.6806 |
| 12:52 ET | 1000 | 0.72193 |
| 02:11 ET | 200 | 0.68 |
| 02:24 ET | 13285 | 0.7 |
| 02:40 ET | 5000 | 0.68 |
| 02:45 ET | 200 | 0.694 |
| 03:18 ET | 100 | 0.68 |
| 03:27 ET | 120 | 0.69145 |
| 03:41 ET | 5000 | 0.6715 |
| 03:45 ET | 2500 | 0.7 |
Mar 28, 2024
DJ Medicine Man Technologies Is Maintained at Buy by Benchmark, from 11:25AM ET on Thursday Mar 28, 2024 by Dow Jones
11:25AM ET on Thursday Mar 28, 2024 by Dow Jones
Mar 27, 2024
Schwazze Announces Fourth Quarter and Full Year 2023 Financial Results, from 4:05PM ET on Wednesday Mar 27, 2024 by Dow Jones
4:05PM ET on Wednesday Mar 27, 2024 by Dow Jones*DJ Medicine Man Technologies 4Q Loss/Shr 43c >SHWZ, from 4:05PM ET on Wednesday Mar 27, 2024 by Dow Jones
4:05PM ET on Wednesday Mar 27, 2024 by Dow JonesPress Release: Schwazze Announces Fourth Quarter and Full Year 2023 Financial Results, from 4:05PM ET on Wednesday Mar 27, 2024 by Dow Jones
4:05PM ET on Wednesday Mar 27, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Medicine Man Technologies Inc | 55.0M | -0.4x | --- |
Shengtai Pharmaceutical Inc | 10.0 | 0.0x | --- |
Lotus Pharmaceuticals Inc | 18.9M | 0.1x | +42.39% |
Cumberland Pharmaceuticals Inc | 22.3M | -3.7x | --- |
Eagle Pharmaceuticals Inc | 57.0M | 4.9x | -4.75% |
Eton Pharmaceuticals Inc | 80.7M | -78.7x | --- |
Company Information
Medicine Man Technologies, Inc., operating as Schwazze, is a vertically integrated multi-state cannabis operator. The Company’s business involves the cultivation, manufacturing, distribution and retail sale of cannabis and cannabis-related products. The Company sells products it manufactures and cultivates and a variety of other cannabis goods through wholly owned retail stores, licensing arrangements, and/or third-party operators and retailers. It has three segments: Retail, Wholesale and Other. The Retail segment consists of retail locations for the sale of cannabis products. The Wholesale segment consists of manufacturing, cultivation and sale of both wholesale cannabis and non-cannabis products. The Other segment encompasses the Company’s general corporate operations, in-store advertisements and certain vendor promotions. It has operations in Colorado and New Mexico. The Company owns and operates 63 retail dispensaries, six cultivation facilities and three manufacturing facilities.
Contact Information
- Headquarters
- 865 N. Albion St., Suite 300DENVER, CO, United States 80220
- Phone
- 303-371-0387
- Fax
- 303-481-4417
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $55.0M |
|---|---|
Revenue (TTM) | $172.4M |
Shares Outstanding | 77.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.50 |
EPS | $-1.60 |
Book Value | $1.61 |
P/E Ratio | -0.4x |
Price/Sales (TTM) | 0.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | 0.77% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
